6-4

Bridging the translational research gap between discovery and treatment,

71

6-5

UC Berkeley IPIRA intellectual property management models,

74

4-1

Examples of Business Models for Funding the Development of Drugs to Treat Rare and Neglected Diseases,

20

5-1

Examples of Data Sharing Models for Biomedical Research,

46

6-1

Managing Strategic Alliances, Licensing, and Intellectual Property: Company, Foundation, and University Perspectives,

56

6-2

Examples of Serendipitous Dual Markets,

61

6-3

Gates Foundation Global Access Agreements,

62

6-4

Examples of Innovations Licensed and/or Funded Under the Socially Responsible Licensing Program (SLRP) at UC Berkeley,

76

6-5

Highlights of “In the Public Interest: Nine Points to Consider in Licensing University Technology,”

78

7-1

Examples of Disease Foundation Strategies for Facilitating Clinical Trials,

84

7-2

FDA Review: Opportunities to Facilitate the Drug Development and Approval Processes,

86